IP Library Granted Patent US 7,875,452
Granted Patent B2
US 7,875,452 · App. 12/285,140 · Granted Jan 25, 2011

Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,452
App. No.
12/285,140
Granted
Jan 25, 2011
Kind
B2
Abstract

There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods, especially electrophysiological, suffer from a lack of sensitivity, rapid signal loss, low throughput, and are labor intensive. The claimed methods and compositions provide electrophysiology methods that allow prolonged sample testing and fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5.

Claims (8)

1. An isolated polynucleotide, wherein the polynucleotide has the sequence of SEQ ID NO: 1.

2. An isolated polynucleotide, wherein the polynucleotide encodes a non-desensitizing TRPM5 ion channel having the sequence of SEQ ID NO: 2.

3. A recombinant vector comprising the isolated polynucleotide of claim 1 .

4. A recombinant vector comprising the isolated polynucleotide of claim 2 .

5. An isolated host cell comprising the vector of claim 3 .

6. A method of making an isolated polypeptide comprising: (a) culturing the host cell of claim 5 under conditions such that said polypeptide is expressed; and (b) recovering said polypeptide.

7. An isolated host cell comprising the vector of claim 4 .

8. A method of making an isolated polypeptide comprising: (a) culturing the host cell of claim 7 under conditions such that said polypeptide is expressed; and (b) recovering said polypeptide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2013
From: REDPOINT BIO CORPORATION
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 030668/0656 →
CORRECTIVE ASSIGNMENT TO ADD AN OMITTED SERIAL NUMBER 60/976,562, PREVIOUSLY RECORDED ON REEL 022356 FRAME 0666. Recorded Jun 24, 2010
From: BRYANT, ROBERT W.; LEE, S. PAUL; CERNE, ROK; BUBER, M.N. TULU; BAKAJ, IVONA; PALMER, ROY KYLE
To: REDPOINT BIO CORPORATION
Reel/Frame 024622/0183 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2009
From: BRYANT, ROBERT W.; LEE, S PAUL; CERNE, ROK; BUBER, M.N. TULU; BAKAJ, IVONA; PALMER, ROY KYLE
To: REDPOINT BIO CORPORATION
Reel/Frame 022356/0666 →